Entecavir for Treatment of Lamivudine-Refractory, HBeAg-Positive Chronic Hepatitis BMorris Sherman, R. Hindes, Cihan Yurdaydın et al.|Gastroenterology|2006Cited by 414
Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trialChristopher Koh, Theo Heller, Stewart Cooper et al.|The Lancet Infectious Diseases|2015Cited by 262
Optimizing lonafarnib treatment for the management of chronic delta hepatitis: The LOWR HDV‐1 studyCihan Yurdaydın, Jeffrey S. Glenn, Onur Keskın et al.|Hepatology|2017Cited by 150
Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countriesHomie Razavi, Ching‐Chih Hu, Marı́a Buti et al.|Journal of Hepatology|2023Cited by 61